Analysis of Ankyrin Repeats Reveals How a Single Point Mutation in RFXANK Results in Bare Lymphocyte Syndrome

REFERENCES

• Alberts, A. S., and R. Treisman. 1998. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J. 17:4075–4085.
   PubMed Web of Science ®Google Scholar
• Axton, J. M., F. L. Shamanski, L. M. Young, D. S. Henderson, J. B. Boyd, and T. L. Orr-Weaver. 1994. The inhibitor of DNA replication encoded by the Drosophila gene plutonium is a small, ankyrin repeat protein. EMBO J. 13:462–470.
   PubMedGoogle Scholar
• Batchelor, A. H., D. E. Piper, F. C. de la Brousse, S. L. McKnight, and C. Wolberger. 1998. The structure of GABPalpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279:1037–1041.
   PubMedGoogle Scholar
• Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681–715.
   PubMed Web of Science ®Google Scholar
• Boss, J. M.. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107–113.
   PubMedGoogle Scholar
• Brotherton, D. H., V. Dhanaraj, S. Wick, L. Brizuela, P. J. Domaille, E. Volyanik, X. Xu, E. Parisini, B. O. Smith, S. J. Archer, M. Serrano, S. L. Brenner, T. L. Blundell, and E. D. Laue. 1998. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d. Nature 395:244–250.
   PubMed Web of Science ®Google Scholar
• Brünger, A. T.. 1992. X-PLOR version 3.1: a system for X-ray crystallography and NMR. Yale University Press, New Haven, Conn
   Google Scholar
• Caretti, G., F. Cocchiarella, C. Sidoli, J. Villard, M. Peretti, W. Reith, and R. Mantovani. 2000. Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. J. Mol. Biol. 302:539–552.
   PubMedGoogle Scholar
• Cogswell, J. P., N. Zeleznik-Le, and J. P. Ting. 1991. Transcriptional regulation of the HLA-DRA gene. Crit. Rev. Immunol. 11:87–112.
   PubMedGoogle Scholar
• Cresswell, P.. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259–293.
   PubMed Web of Science ®Google Scholar
• DeSandro, A. M., U. M. Nagarajan, and J. M. Boss. 2000. Associations and interactions between bare lymphocyte syndrome factors. Mol. Cell. Biol. 20:6587–6599.
   PubMedGoogle Scholar
• Durand, B., P. Sperisen, P. Emery, E. Barras, M. Zufferey, B. Mach, and W. Reith. 1997. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J. 16:1045–1055.
   PubMedGoogle Scholar
• Fontes, J. D., B. Jiang, and B. M. Peterlin. 1997. The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. Nucleic Acids Res. 25:2522–2528.
   PubMed Web of Science ®Google Scholar
• Fontes, J. D., S. Kanazawa, N. Nekrep, and B. M. Peterlin. 1999. The class II transactivator CIITA is a transcriptional integrator. Microbes Infect. 1:863–869.
   PubMedGoogle Scholar
• Foord, R., I. A. Taylor, S. G. Sedgwick, and S. J. Smerdon. 1999. X-ray structural analysis of the yeast cell cycle regulator Swi6 reveals variations of the ankyrin fold and has implications for Swi6 function. Nat. Struct. Biol. 6:157–165.
   PubMedGoogle Scholar
• Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13–49.
   PubMed Web of Science ®Google Scholar
• Gorina, S., and N. P. Pavletich. 1996. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274:1001–1005.
   PubMed Web of Science ®Google Scholar
• Jacobs, M. D., and S. C. Harrison. 1998. Structure of an IkappaBalpha/NF-kappaB complex. Cell 95:749–758.
   PubMed Web of Science ®Google Scholar
• Kraulis, P. J.. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946–950.
   Web of Science ®Google Scholar
• Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301–331.
   PubMed Web of Science ®Google Scholar
• Mandiyan, V., J. Andreev, J. Schlessinger, and S. R. Hubbard. 1999. Crystal structure of the ARF-GAP domain and ankyrin repeats of PYK2-associated protein beta. EMBO J. 18:6890–6898.
   PubMedGoogle Scholar
• Masternak, K., E. Barras, M. Zufferey, B. Conrad, G. Corthals, R. Aebersold, J. C. Sanchez, D. F. Hochstrasser, B. Mach, and W. Reith. 1998. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20:273–277.
   PubMedGoogle Scholar
• Michaely, P., and V. Bennett. 1993. The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats. J. Biol. Chem. 268:22703–22709.
   PubMed Web of Science ®Google Scholar
• Nagarajan, U. M., P. Louis-Plence, A. DeSandro, R. Nilsen, A. Bushey, and J. M. Boss. 1999. RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153–162.
   PubMedGoogle Scholar
• Nagarajan, U. M., A. Peijnenburg, S. J. Gobin, J. M. Boss, and P. J. van den Elsen. 2000. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells. J. Immunol. 164:3666–3674.
   PubMedGoogle Scholar
• Nekrep, N., N. Jabrane-Ferrat, and B. M. Peterlin. 2000. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex. Mol. Cell. Biol. 20:4455–4461.
   PubMedGoogle Scholar
• Nicholls, A., K. A. Sharp, and B. Honig. 1991. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11:281–296.
   PubMed Web of Science ®Google Scholar
• Peitsch, M. C.. 1996. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:274–279.
   PubMed Web of Science ®Google Scholar
• Russo, A. A., L. Tong, J. O. Lee, P. D. Jeffrey, and N. P. Pavletich. 1998. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature 395:237–243.
   PubMed Web of Science ®Google Scholar
• Sedgwick, S. G., and S. J. Smerdon. 1999. The ankyrin repeat: a diversity of interactions on a common structural framework. Trends Biochem. Sci. 24:311–316.
   PubMed Web of Science ®Google Scholar
• Steimle, V., B. Durand, E. Barras, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021–1032.
   PubMedGoogle Scholar
• Zhang, Z., P. Devarajan, A. L. Dorfman, and J. S. Morrow. 1998. Structure of the ankyrin-binding domain of alpha-Na,K-ATPase. J. Biol. Chem. 273:18681–18684.
   PubMed Web of Science ®Google Scholar
• Zhu, X. S., M. W. Linhoff, G. Li, K. C. Chin, S. N. Maity, and J. P. Ting. 2000. Transcriptional scaffold: CIITA interacts with NF-Y, RFX, and CREB to cause stereospecific regulation of the class II major histocompatibility complex promoter. Mol. Cell. Biol. 20:6051–6061.
   PubMed Web of Science ®Google Scholar